BENEŠ, Petr, Michal JURAJDA, Jan ŽALOUDÍK, Lydie IZAKOVIČOVÁ HOLLÁ and Jiří VÁCHA. C766T low-density lipoprotein receptor-related protein 1 ( LRP1) gene polymorphism and susceptibility to breast cancer. Breast Cancer Research. 2003, vol. 5, No 3, p. 77-81. ISSN 1465-542X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name C766T low-density lipoprotein receptor-related protein 1 ( LRP1) gene polymorphism and susceptibility to breast cancer
Name in Czech Genový polymorfismus C766T v genu pro low-density lipoprotein receptor-related protein 1 ( LRP1) a náchylnost ke karcinomu prsu
Authors BENEŠ, Petr (203 Czech Republic, guarantor), Michal JURAJDA (203 Czech Republic), Jan ŽALOUDÍK (203 Czech Republic), Lydie IZAKOVIČOVÁ HOLLÁ (203 Czech Republic) and Jiří VÁCHA (203 Czech Republic).
Edition Breast Cancer Research, 2003, 1465-542X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.932
RIV identification code RIV/00216224:14110/03:00009856
Organization unit Faculty of Medicine
UT WoS 000183439400004
Keywords in English breast cancer; case-control study; genetic polymorphism; low-density lipoprotein receptor-related protein 1
Tags breast cancer, case-control study, genetic polymorphism
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Lydie Izakovičová Hollá, Ph.D., učo 734. Changed: 17/6/2009 12:32.
Abstract
Background: Low-density lipoprotein receptor-related protein 1 (LRP1) is a multifunctional endocytic receptor with an important role in regulating the activity of proteinases in extracellular matrix. Several studies have also described its role in intracellular signaling. Previous studies showed that the expression of LRP1 is related to invasiveness of cancer cells. However, recent data on LRP1 suggest that this receptor can also be involved in tumor establishment and progression. Methods: We investigated an association between the C766T polymorphism of the third exon of the LRP1 gene and breast cancer in a sample of women of Caucasian origin. Allele and genotype frequencies of this polymorphism were assessed in 164 women with breast cancer and in 183 age-compatible women without a history of any cancer disease. Results: An increase in LRP1 T allele frequency in subjects with breast cancer was observed compared with controls (0.21 versus 0.15, P=0.01963). A significant excess of genotypes with the T allele (homozygotes plus heterozygotes) was also observed (odds ratio 1.743, 95% confidence interval 1.112-2.732). Conclusion: The T allele of the C766T polymorphism in the LRP1 gene is associated with an increased risk of breast cancer development in women of Caucasian origin.
Abstract (in Czech)
"Low-density lipoprotein receptor-related protein 1" (LRP1) je multifunkční endocytický receptor s důležitou rolí při regulaci aktivity proteáz v extracelulární matrix. Několik studií popsalo také jeho roli ve vnitrobuněčné signalizaci. Bylo prokázáno, že exprese LRP1 má vztah k invazivitě nádorových buněk. Podle nedávných zjištění se však LRP1 může podílet také na nádorové transformaci buněk. V naší práci jsme studovali asociaci mezi genovým polymorfizmem C766T ve třetím exonu genu pro LRP1 a karcinomem prsu na vzorku žen indoevropské rasy. Alelické a genotypové frekvence sledovaného polymorfizmu byly určeny u 164 žen s karcinomem prsu a u 183 věkově odpovídajících kontrol. Mezi ženami s karcinomem prsu byla pozorována větší četnost alely T sledovaného polymorfizmu v porovnání s kontrolní populací (0.21 versus 0.15, P=0.01963). Bylo pozorováno také signifikantně větší zastoupení nositelek alespoň jedné T alely (homozygotů a heterozygotů) mezi pacientkami s karcinomem prsu (poměr šancí 1.743, 95% interval spolehlivosti 1.112-2.732). Alela T polymorfizmu C766T v LRP1 genu je asociována se zvýšeným rizikem rozvoje karcinomu prsu u žen indoevropské rasy.
Links
MSM 141100002, plan (intention)Name: Molekulární patofyziologie multigenních chorob
Investor: Ministry of Education, Youth and Sports of the CR, Molecular pathophysiology of multigene diseases
PrintDisplayed: 26/4/2024 19:47